393 related articles for article (PubMed ID: 34915433)
1. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord: an allogenic tissue for potential treatment of COVID-19.
Rodriguez HC; Gupta M; Cavazos-Escobar E; El-Amin SF; Gupta A
Hum Cell; 2021 Jan; 34(1):1-13. PubMed ID: 33033884
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
4. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
Khanh VC; Fukushige M; Chang YH; Hoang NN; Yamashita T; Obata-Yasuoka M; Hamada H; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2021 Aug; 30(15):758-772. PubMed ID: 34074129
[TBL] [Abstract][Full Text] [Related]
5. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
Riedel RN; Pérez-Pérez A; Sánchez-Margalet V; Varone CL; Maymó JL
Stem Cell Res Ther; 2021 Mar; 12(1):155. PubMed ID: 33648582
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
[TBL] [Abstract][Full Text] [Related]
8. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
10. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.
Russo E; Corrao S; Di Gaudio F; Alberti G; Caprnda M; Kubatka P; Kruzliak P; Miceli V; Conaldi PG; Borlongan CV; La Rocca G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371134
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
12. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
13. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
Front Immunol; 2021; 12():738697. PubMed ID: 34659231
[TBL] [Abstract][Full Text] [Related]
14. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract][Full Text] [Related]
15. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
18. Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion.
Witkowska-Zimny M; Wrobel E
Cell Mol Biol Lett; 2011 Sep; 16(3):493-514. PubMed ID: 21786036
[TBL] [Abstract][Full Text] [Related]
19. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
[TBL] [Abstract][Full Text] [Related]
20. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
[Next] [New Search]